Global Financial Private Client’s VanEck Biotech ETF BBH Stock Holding History

Global Financial Private Client’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-44	Closed	-$7.27K	–	703
2023 Q4	$7.27K	Hold	44	–	–	﹤0.01%	488
2023 Q3	$6.79K	Hold	44	–	–	﹤0.01%	479
2023 Q2	$6.86K	Hold	44	–	–	﹤0.01%	471
2023 Q1	$7.13K	Hold	44	–	–	﹤0.01%	483
2022 Q4	$7.03K	Hold	44	–	–	﹤0.01%	461
2022 Q3	$6.31K	Hold	44	–	–	﹤0.01%	449
2022 Q2	$6.56K	Hold	44	–	–	﹤0.01%	439
2022 Q1	$7.3K	Hold	44	–	–	﹤0.01%	439
2021 Q4	$8.33K	Hold	44	–	–	﹤0.01%	412
2021 Q3	$8.65K	Hold	44	–	–	﹤0.01%	366
2021 Q2	$8.92K	Hold	44	–	–	0.01%	373
2021 Q1	$7.79K	Hold	44	–	–	0.01%	326
2020 Q4	$7.47K	Sell	44 -35	-44%	-$5.77K	0.01%	326
2020 Q3	$12.9K	Sell	79 -109	-58%	-$17.7K	0.01%	294
2020 Q2	$31K	Sell	188 -511	-73%	-$77.7K	0.03%	257
2020 Q1	$87K	Hold	699	–	–	0.09%	158
2019 Q4	$97.5K	Buy	+699	New	+$91.9K	0.08%	169

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

CIG

Consolidated Investment Group Englewood, Colorado $922M AUM 28.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Global Financial Private Client's BBH Position: Q1 2024 in Review

Global Financial Private Client sold out of VanEck Biotech ETF (BBH) in Q1 2024, closing a stake of 44 shares — an estimated $7.27K sold.

Global Financial Private Client first reported a position in BBH in Q4 2019 and held it in 17 quarters. The position peaked at $97.5K in Q4 2019. 113 funds tracked by Wall St. Rank hold BBH as of Q1 2024.

Global Financial Private Client reported no remaining VanEck Biotech ETF position as of Q1 2024 after selling out during the quarter.
Global Financial Private Client sold 44 VanEck Biotech ETF shares in Q1 2024, an estimated $7.27K.
Global Financial Private Client first reported a position in VanEck Biotech ETF in Q4 2019 and held it in 17 quarters.
Global Financial Private Client's VanEck Biotech ETF position peaked at $97.5K in Q4 2019.
113 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2024.

Based on Global Financial Private Client's 13F filing for Q1 2024, filed 16 May 2024.